Author: Dr Anika Schröter
The development of RNA-based drugs has increased within the past years and is a promising field of research in the pharmaceutical industry. It is transforming the industry and will offer new hope for patients with unmet medical needs.
RNA-based drugs have several advantages over conventional drugs, such as the ability to target previously undruggable pathways, the rapid and cost-effective development, and the potential for personalized medicine. However, RNA-based drugs also face some challenges, such as the stability, delivery, and safety of the RNA molecules.
This whitepaper informs about the challenges with the 'standard' non-clinical program for different RNA-based drugs, focusing on safety evaluation.
Download now the white paper 'Non-clinical aspects of RNA-based drug development'.
We hope you enjoy reading it!
With this qualification course, you can continue your education in a structured manner in all global regulatory affairs topics, with a regional or country-specific focus.
The EU's Recovery and Resilience Facility (RRF) is an essential part of the EU's economic recovery plan, providing grants and loans to member states. Since its launch in 2021, implementation has been uneven across EU countries. What are the reasons for these differences in implementation between EU countries, and how can one navigate the new system for successful RRF funding?
IP Strategist - the interactive online course which helps you setting up convincing IP strategy plans.
Our speakers will give you tips and tricks on EP claim drafting and will show you which pitfalls to avoid.
The conference offers you once again the most recent developments in IP for the seed industry and the breeders.
RNA-based drugs and oligonucleotides: gain a solid understanding of the complexities involved in the development and regulatory approval of RNA-based drugs and oligonucleotides. Meet outstanding and longtermin experienced experts in the field of research.
An online seminar to discuss real cases/challenges for marketing authorisation in Mexico, Argentina, Colombia, Peru, Chile and Brazil with local experts from Brazil and Spain.
The IP Management in Practice online course was developed in cooperation with a network of experienced IP Managers, IP Directors, and Heads of IP working in various industries and from private practice. Each course day includes a mix of theory and practice. The course content has been chosen with regard to practical application in daily practice.
Our global and local experts will update you every two months with the latest regulatory and legislative developments. Thus, you will always have the essential information and trends in regulatory affairs at your fingertips!
Our biotech experts will provide you with the latest information on issues related to development, quality and regulatory affairs of biologics every month in a two-hour webcast, in particular with regard to CMC.
